Clementi M, Menzo S, Manzin A, Bagnarelli P
Istituto di Microbiologia, Università di Ancona, Italy.
Arch Virol. 1995;140(9):1523-39. doi: 10.1007/BF01322527.
During the past few years, significant technical effort was made to develop molecular methods for the absolute quantitation of nucleic acids in biological samples. In virology, semi-quantitative and quantitative techniques of different principle, complexity, and reliability were designed, optimized, and applied in basic and clinical researches. The principal data obtained in successful pilot applications in vivo are reported in this paper and show the real usefulness of these methods to understand more details of the natural history of viral diseases and to monitor specific anti-viral treatments in real time. Theoretical considerations and practical applications indicate that the competitive polymerase chain reaction (cPCR) and competitive reverse-transcription PCR (cRT-PCR) assay systems share several advantages over other quantitative molecular methodologies, thus suggesting that these techniques are the methods of choice for the absolute quantitation of viral nucleic acids present in low amounts in biological samples. Although minor obstacles to a wide use of these quantitative methods in clinical virology still remain, further technical evolution is possible, thus making the quantitative procedures easier and apt to routine applications.
在过去几年中,人们付出了巨大的技术努力来开发用于绝对定量生物样品中核酸的分子方法。在病毒学领域,设计、优化了不同原理、复杂性和可靠性的半定量和定量技术,并将其应用于基础研究和临床研究。本文报道了在体内成功进行的先导应用中获得的主要数据,这些数据表明这些方法对于更详细地了解病毒疾病的自然史以及实时监测特定的抗病毒治疗具有实际用途。理论思考和实际应用表明,竞争性聚合酶链反应(cPCR)和竞争性逆转录PCR(cRT-PCR)检测系统比其他定量分子方法具有多个优势,因此表明这些技术是绝对定量生物样品中低含量病毒核酸的首选方法。尽管在临床病毒学中广泛使用这些定量方法仍存在一些小障碍,但进一步的技术发展是可能的,从而使定量程序更简便且适合常规应用。